Community Schedule

Enter at least 4 characters

1 results showing for: 'octocog alfa [recombinant factor viii] (advate)'

Octocog alfa [Recombinant factor VIII] (Advate)    Medsafe Data Sheets   New Zealand Formulary.   Hospital Medicines List.   PDF Schedule - Refer from page 39.
[Xpharm]
  • Inj 250 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292696
    • Subsidy $210.00
    • Measure / Qty per 1
  • Inj 500 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292718
    • Subsidy $420.00
    • Measure / Qty per 1
  • Inj 1,000 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292726
    • Subsidy $840.00
    • Measure / Qty per 1
  • Inj 1,500 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292742
    • Subsidy $1260.00
    • Measure / Qty per 1
  • Inj 2,000 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292750
    • Subsidy $1680.00
    • Measure / Qty per 1
  • Inj 3,000 iu vial
    • Brand Fully subsidised brand. Advate
    • Pharmacode2292769
    • Subsidy $2520.00
    • Measure / Qty per 1

For patients with haemophilia. Preferred Brand of short half-life recombinant factor VIII. Access to funded treatment is managed by the Haemophilia Treaters Group in conjunction with the National Haemophilia Management Group.

  • Rectangle page icon symoblising a PDF. PDF
  • A tick icon. Fully subsidised
  • An oval with the number 29 in it. Unapproved medicine under Section 29
  • An asterisk symbol. 3 or 6 months should be dispensed at once
  • Two duplicate pages icon. Click to copy
  • A triangle symbol. Three months supply may be dispensed at one time if endorsed "certified exemption" by the prescriber or pharmacist.
  • OP Original pack
  • Sole Subsidised Supply